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CHARACTERIZATION OF THE INTERACTIONS BETWEEN STAPHYLOCOCCAL
PHAGE 80 ALPHA SCAFFOLD AND CAPSID PROTEINS
By Laura Ann Klenow
A thesis submitted in partial fulfillment of the requirement for the degree of Master of
Science at Virginia Commonwealth University.

Virginia Commonwealth University, 2015
Major Director: Gail E. Christie, Ph.D.
Professor, Department of Microbiology and Immunology

Staphylococcal phage 80α can serve as a helper bacteriophage for a family of mobile
genetic elements called Staphylococcus aureus pathogenicity islands (SaPIs). The
prototype island, SaPI1, is able to hijack the 80α capsid assembly process and redirect
capsid formation to yield smaller, phage-like transducing particles carrying SaPI DNA.
Capsid size redirection is accomplished through two SaPI1-encoded gene products,
CpmA and an alternate scaffold protein, CpmB. The normal 80α scaffold and the SaPI1
CpmB scaffold share a small block of conserved residues at their C-termini, several of
which had been shown to be essential for CpmB function. This led to the hypothesis that

the C-termini of both the phage and SaPI scaffolds interact in similar ways with the major
capsid protein. The goal of this study was to test this hypothesis and to identify the amino
acid residues at the capsid-scaffold interface, using a genetic approach.

Chapter 1
Introduction

Staphylococcus aureus virulence and mobile genetic elements
Staphylococcus aureus is a widespread Gram-positive bacterium that is commonly
found as a normal inhabitant of human skin and the mucosal epithelia. It is estimated that
20% of individuals’ anterior nares are persistently colonized, with approximately 30% of
the population intermittently colonized (Gordon et al., 2008). While S. aureus is generally
a commensal bacterium, it is in possession of a vast array of virulence factors and toxins
that are capable of causing an assortment of systemic and local infections (Xia et al.,
2013). Antibiotic resistance in S. aureus arose two years after the introduction of
methicillin and has been increasing in prevalence in the clinical setting since that time
(Jevons, 1961). Nosocomial S. aureus infections are the second most reported hospital
acquired infections and while the majority of resistant strains were reported in clinical
settings, community acquired (CA)-MRSA cases, or incidents where the persons infected
had no prior hospitalizations, are on the rise as well (Archer, 2008; Knox et al. 2015;
Lowy, 2003).
While antibiotic resistance is a valid concern, the pathogenicity of S. aureus ranges
from causing local skin abscesses all the way to disseminated septic shock, due in large
part to a host of over 20 known virulence factors (Archer, 1998). Virulence factors can be
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acquired through the highly promiscuous nature of bacterial horizontal gene transfer
(HGT). HGT is accomplished through a variety of mechanisms, as virulence genes and
toxins are often carried by mobile genetic elements (MGEs) such as bacteriophages,
pathogenicity islands, and plasmids (Novick, 2003). Along these lines, S. aureus can be
parasitized by staphylococcal phage 80α, which on its own is able to transfer
chromosomal and plasmid-encoded genes through generalized transduction (Dyer et al.
1985). However, adding another layer of complexity to the issue is the fact that 80α can
also

mediate

specific

high-frequency

transduction

of

Staphylococcus

aureus

pathogenicity islands (SaPIs) which also carry genes for several virulence factors, such
as the toxic shock syndrome toxin (Novick, 2003).

Bacteriophage 80α and the molecular pirate SaPI1
Staphylococcal bacteriophage 80α is a temperate, double-stranded DNA (dsDNA)
phage of the family Siphoviridae (Christie et al,. 2010). The mature 80α virion has a 63
nm diameter, icosahedral capsid with T=7 symmetry. Attached to the capsid is a 190 nm
long non-contractile, flexuous tail with an elaborate baseplate that is studded with six tail
fibers (Spilman et al., 2011). 80α is a temperate bacteriophage, meaning that it can reside
as a stable lysogen integrated into the host staphylococcal chromosome, or alternatively
infect the cell and cause lysis after a productive phage infection (Christie et al., 2010).
Most dsDNA, tailed bacteriophages replicate in a similar manner. After infecting a
cell and shutting down certain host cell macromolecular synthesis processes in favor of
preferentially producing phage components, a small, empty prohead structure is formed
by the aggregation of scaffold-chaperoned capsid proteins (Rossman, 2013). Later in the
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assembly process, the genome is packaged through the portal into the procapsid. DNA
packaging is an energy consuming process and is powered by the small and large
subunits of terminase, which are ATP dependent (Rossman, 2013). While the genome is
packaged, the internal scaffolding protein exits and the procapsid expands to a larger,
DNA-filled mature capsid (Prevelige et al., 2012).
The staphylococcal phage 80α follows a similar pathway (Figure 1). The 80α
capsid assembly pathway involves formation of an empty, transient procapsid composed
of 415 copies of the major capsid protein, gene product (gp) 47; 100-200 copies of the
scaffold protein, gp46; a portal protein, gp42; and approximately 20 copies of an
uncharacterized minor capsid protein, gp44 (Tallent et al., 2007; Poliakov et al., 2008).
Like other tailed dsDNA bacteriophages, the capsid protein of 80α shows a conformation
similar to that first described in phage HK97, the so-called HK97 fold (Johnson, 2010).
During procapsid assembly, scaffold protein gp46 serves as a chaperone for the
aggregation of major capsid protein gp47. Both gp46 and gp47 are N-terminally cleaved
by 13 and 14 residues, respectively, between phenylalanine and alanine residues within
a conserved amino acid sequence motif (Poliakov et al., 2008). This cleavage is carried
out by a host-encoded cysteine protease, phage-related ribosomal protease (Prp) (Wall
et al., 2015). Procapsid expansion and maturation is dependent upon a conformational
change involving a proline at residue 132 (P132) in gp47 (Spilman et al., 2011). 80α
procapsid expansion involves dynamic remodeling of the surface gp47 proteins due to
the rotational effects of P132 altering its angle in the spine helix of capsid, resulting in an
expansion that roughly doubles the volume of the procapsid (Spilman et al., 2011).
Procapsid expansion occurs simultaneously with the release of gp46, and the headful
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Figure 1: Schematic of 80α capsid assembly and the SaPI1 CpmA and CpmB redirection of 80α capsid assembly.
80α scaffolding protein, gp46, serves as a chaperone for the proper aggregation of major capsid protein, gp47. Upon DNA
packaging, the procapsid expands to form a mature virion. In the presence of the SaPI1 encoded CpmA and CpmB capsid
size redirection genes, SaPI1 forms a smaller procapsid, resulting in a transducing particle that is approximately one-third
the volume of the mature 80α virion.
4

packaging of the dsDNA genome by the small (gp40, TerS) and large (gp41, TerL)
terminase subunits, resulting in a mature capsid (Spilman et al., 2011). Following capsid
maturation, the non-contractile tail attaches to the capsid via gp42 resulting in a mature,
viable virion.
However, instead of one possible outcome, the mature viable phage virion, there
is a second route of capsid assembly possible. Phage 80α also serves as a “helper”
phage that aids in the mobilization of several SaPIs. SaPIs are a class of MGEs, roughly
14-27 kb in size, that stably integrate into the host chromosome and often carry antibiotic
resistance and toxin genes (Novick et al., 2010). SaPIs are considered molecular pirates
because they package their own genomes into transducing particles comprised of helper
phage-encoded proteins. One striking feature of this appropriation of the helper phage by
a SaPI is redirection of the capsid assembly process to construct T=4 capsids with onethird the volume of the mature 80α capsid (Christie et al., 2012). This difference in capsid
size directly parallels the disparity between the genome sizes of 80α (~44 kb) and the
prototypical pathogenicity island used in this work, SaPI1 (~15 kb). While SaPI1 can
package its genome into either a small or large capsid, 80α is unable to package its
complete genome into the smaller SaPI1 transducing particle. Furthermore, SaPI1
preferentially packages its own genome using a SaPI1-encoded small terminase subunit
(Ubeda et al., 2009). This results in interference with helper phage propagation and the
efficient assembly of SaPI1 transducing particles from the phage structural proteins
(Figure 2).
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Figure 2: Model for high frequency SaPI1 transduction
Following phage infection or the induction of a lysogenic prophage, SaPI1 excises from the S. aureus chromosome, recircularizes and begins replicating, packaging its DNA preferentially in small capsids. Upon lysis, progeny phage and SaPI1
transducing particles are released, and are able to propagate throughout S. aureus, infecting naïve cells.
6

SaPI1 mobilization via helper phage 80α
Upon infection by 80α or the induction of an 80α prophage from the host cell
chromosome by the SOS response, a phage-encoded anti-repressor, Sri inhibits the
SaPI1 repressor, Stl (Tormo-Mas et al., 2010). The SOS response is a global cellular
response that is activated when DNA damage is so widespread that normal DNA repair
mechanisms are ineffective (Willey, 2014). This derepression results in expression of
SaPI1 genes leading to excision of SaPI1 from the host chromosome and its subsequent
replication. With such a small genome, it is not surprising that SaPIs rely heavily on 80α
for transducing particle assembly. Due to this ability to redirect capsid assembly, there is
usually a one-hundred fold reduction in phage titer when there is also a SaPI present in
the host cell. The completed SaPI1 transducing particles are now able to infect other
naïve host cells upon lysis, potentially transferring virulence or toxin genes to the
surrounding bacterial population (Figure 2).

Phage 80α capsid assembly and its interaction with alternative scaffolds
Capsid assembly is an essential process in the formation of mature 80α virions
and SaPI1 transducing particles. As previously discussed, phage 80α capsid assembly
begins with the gp46 scaffold acting as a chaperone protein for gp47 (Dokland, 1999).
The 80α procapsid is formed from multiple copies of gp46, gp47, the portal protein gp42,
and the minor capsid protein gp44. Prior to, or concurrently with procapsid expansion and
DNA packaging, the gp46 scaffolding proteins are lost. In the presence of SaPI1, the 80α
capsid protein gp47 interacts with the SaPI1-encoded alternate scaffold, CpmB or gp6
(Dearborn et al., 2011). A second SaPI encoded gene, cpmA or gp7, is also involved in

7

forming small capsids, but its role is not well understood. The internal structures of 80α
and SaPI1 procapsids are significantly different. Cryo-EM reconstructions of the
procapsids revealed finger-like projections that extend towards the center of the
procapsid of SaPI1 which were completely absent in 80α. Previous studies have shown
that these finger-like densities are consistent with CpmB, the alternate scaffold protein,
which forms a scaffold-like dimer that then associates with phage capsid (Dearborn et al.,
2011). The interaction between 80α capsid with two alternative scaffolds, the native
phage scaffold protein and the alternate scaffold produced by SaPI1, is a unique feature
of the system.
The specific interactions between capsid and these two different scaffolding
proteins are not well understood at this time. Previous work in our lab suggests that the
C-terminus of SaPI1 scaffold is involved in the interaction with the phage capsid protein
(E.A. Wall, unpublished). Similarities between the C-terminus of the phage and SaPI1
scaffold proteins suggest that both scaffold proteins interact with major capsid protein
gp47 in a similar manner.
The goal of this study was to investigate the residues involved in the 80α
scaffold:capsid interface and determine whether these interactions were shared with the
phage capsid and SaPI1 scaffold. Secondly, the role of N-terminal proteolytic cleavage
of gp46 and gp47 in assembly of phage capsids and SaPI1 transducing particles was
explored.
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Chapter 2
Materials and Methods

Note: All reagents used in this work were acquired through major suppliers including
Fisher Scientific (Waltham, MA), and Sigma-Aldrich (St. Louis, MO), unless indicated
otherwise.

2.1 Bacterial Culture
All bacterial strains used in this work are listed in Table 1. S. aureus cultures were
grown overnight in Luria-Bertani (LB) broth (Fisher Scientific, Waltham, MA), or Tryptic
Soy Broth (TSB) (Fisher Scientific, Waltham, MA). All broth cultures were incubated at
37°C on an orbital shaker at 200 rpm. S. aureus cultures were also grown on LB agar
plates (1.8% agarose) and Tryptic Soy Agar (TSA) plates (1.8% agarose) and incubated
overnight at 30°C. When necessary, the media was supplemented with erythromycin (5
µg/ml). S. aureus strains carrying 80α prophage were plated on beta-glycerophosphate
disodium salt pentahydrate (GL) agar (Novick, 1991) and incubated overnight at 30°C.
Escherichia coli strains were incubated overnight at 37°C on either LB or TSA plates,
in addition to being grown in LB broth or TSB. Media for use with E. coli strains was
supplemented with ampicillin (100 µg/ml) when needed.
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Table 1: Bacterial strains used in this study
S. aureus
Background
Integrated Prophage/SaPI
Strains
RN4220

4220

None

RN10616

4220

80α

RN10628

4220

80α SaPI1 tst::tetM

ST91
ST247
ST248
ST278
ST279
ST358
ST361
ST365
ST366
ST367
ST368
ST375
ST376
ST377
ST378
E. coli Strain
Stellar™
Competent Cells

80α ∆gp46
80α gp46 ∆2-13
80α ∆gp47
80α gp46 R202S
80α gp46 R202E
80α gp46 I203T
80α gp47 F14A
ST247 + SaPI1
ST278 + SaPI1
ST279 + SaPI1
ST358 + SaPI1
80α gp47 E50R
80α gp47 E53R
80α gp46 R202E + gp47 E50R
80α gp46 R202E + gp47 E53R
Description
HST08 derivative, high transformation
efficiency strain. E. coli F–, endA1, supE44, thi1, recA1, relA1, gyrA96, phoA, Φ80d
lacZΔM15, Δ(lacZYA-argF)U169, Δ(mrrhsdRMS-mcrBC), ΔmcrA, λ–
4220
4220
4220
4220
4220
4220
4220
4220
4220
4220
4220
4220
4220
4220
4220
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Reference
Kreiswirth, B.N., et
al., 1983.
Ubeda, C., et al.,
2009.
Ubeda, C., et al.,
2009.
Lab strain
Lab strain
Lab strain
Lab strain
Lab strain
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Source

Clontech

2.2 DNA Manipulations: Plasmid Construction

All plasmids used or created for this work are listed in Table 2. Restriction
endonucleases, restriction enzyme buffers, and bovine serum albumin (BSA) used for
DNA manipulations were purchased from New England Biolabs (Ipswich, MA) and were
used in accordance with the manufacturer’s instructions. Restriction digests were
performed in a volume of 25 µl, or multiples thereof, depending upon the downstream
application(s) of the DNA product(s). Plasmid construction was accomplished through
polymerase chain reaction (PCR) amplification of the desired insert, vector preparation
(including PCR purification, restriction enzyme digestion, and gel extraction), In-Fusion
reaction and finally confirmation of the construct through Sanger sequencing. Plasmid
DNA preparations were performed using the QIAprep®Spin Miniprep Kit (Qiagen;
Valencia, CA) in accordance with the manufacturer’s instructions. Plasmid DNA was
eluted in warmed (65°C) HPLC-grade water for DNA sequencing. All PCR products were
analyzed and/or prepared for PCR purification using agarose gel electrophoresis. PCR
products were purified using the QIAquick PCR Purification Kit (Qiagen; Valencia, CA)
and gel extractions were performed using the Nucleospin® Gel and PCR Clean-up Kit
(Macherey-Nagel; Düren, Germany) in accordance with the manufacturer’s instructions.
All DNA concentrations were determined using a Nanodrop 1000 spectrophotometer
(Thermo Scientific; Waltham, MA). The Infusion® HD cloning kit (Clontech; Mountain
View, CA), which utilizes the Gibson assembly method (Gibson, 2011), was used instead
of an insert-vector ligation in accordance with the manufacturer’s instructions. All
plasmids were verified by Sanger sequencing through Eurofins MWG Operon.
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Table 2: Plasmids created or used for this this study
Plasmid
Description
pLAK1
pMAD derivative with 80α gp46 mutation I203T
pLAK2
pMAD derivative with 80α gp47 mutation E50R
pLAK3
pMAD derivative with 80α gp47 mutation E53R
pLAK4
pMAD derivative with 80α gp46 mutation R202E and gp47
mutation E50R
pLAK5
pMAD derivative with 80α gp46 mutation R202E and gp47
mutation E53R
pMAD
Shuttle vector used for allelic exchange in Gram-positive
bacteria
pMED2
pMAD derivative with 80α gp47 mutation F14A
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Reference
This study
This study
This study
This study
This study
Arnaud et al.,
2004
Lab Strain

2.3 Polymerase Chain Reaction (PCR)
PCR reactions were performed using a T-Gradient Thermoblock thermocycler
(Biometra; Gottingen, Germany). Primers listed in Table 3 were obtained from Integrated
DNA Technologies (Coralville, IA). The lyophilized primers were reconstituted with HPLCgrade water to a final concentration of 1 mM. Primer working stock aliquots were prepared
by 1:100 dilution with HPLC-grade water to 10 µM. All inserts were amplified using
PfuUltra II Fusion HS DNA Polymerase (Agilent Technologies; Santa Clara, CA) in the
following manner: 1x PfuUltra II reaction buffer (Agilent Technologies; Santa Clara, CA),
100 µM dNTPs (Invitrogen; Grand Island, NY), 5-30 ng vector DNA input template, 0.2
µM of both the forward and reverse primers, and 0.5 µl of PfuUltra II Fusion HS DNA
polymerase, and brought to a final reaction volume of 50 µl. All PCR reaction master
mixes were scaled up as needed with 10% excess to account for pipetting error. The
following PCR parameters were followed for targets <10 kb: initial denaturation for 2
minutes at 95°C, followed by 34 cycles of denaturation for 20 seconds at 95°C, primer
annealing for 15 seconds, and primer extension for 15 seconds per kb of target DNA at
72°C. A final 3 minute primer extension step was performed at 72°C. All reactions were
kept at 4°C following the final extension prior to being stored at -20°C. Annealing
temperatures for each primer were optimized based on the melting temperature (Tm) of
each primer, as shown in Table 3, and were generally the average Tm-5°C.
Colony PCR was performed by preparing the DNA template as follows: 1 isogenic
colony was picked and smeared in an even layer into a sterile PCR tube,
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Table 3: Primers used in this study
Primer

EAW5
EAW159
EAW8
EAW160

Tm
(°C)

DNA
Template

F

58.6

RN10616

R

59.3

RN10616

R

56.0

RN10616

F

57.6

RN10616

F

55.8

RN10616

R

57.9

RN10616

R

57.0

RN10616

F

57.9

RN10616

F

55.8

RN10616

R

59.3

RN10616

R

57.0

RN10616

F

57.2

RN10616

F

55.8

ST279

R

57.9

ST279

R

57.0

ST279

F

57.9

ST279

F

55.8

ST279

R

59.3

ST279

Sequence (5’-3’)
Direction
Plasmid Construction Primers
pLAK1
CGATGCATGCCATGG*TGGTCGAAAA
CAAGGACTTTAGCGATAG
TTTAAT(CG)TTCTTTT*TTGTCTAGCTA
TTTCAGCTAAGTTTTGCG
GGCGATATCGGATCC*TTCCAATGAT
TTCGGGCATGTTAC
AAAAGAA(CG)ATTAAA*AATTAACGGA
GGCATTTAAATGGAACAAAC

pLAK2
EAW58
EAW171
EAW61
EAW172

CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC
CATAAC(ACG)TTGTAA*GATGGGCGT
TGTGAATTCATTC
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC
TTACAA(CGT)GTTATG*GAAAACTCTA
AAATTATGCAATTAGGTAAGTACG

pLAK3
EAW58
EAW173
EAW61
EAW174

CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC
AGAGTT(ACG)CATAAC*CTCTTGTAAG
ATGGGCGTTG
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC
GTTATG(CGT)AACTCT*AAAATTATGC
AATTAGGTAAGTACGAACC

pLAK4
EAW58
EAW171
EAW61
EAW172

CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC
CATAAC(ACG)TTGTAA*GATGGGCGT
TGTGAATTCATTC
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC
TTACAA(CGT)GTTATG*GAAAACTCTA
AAATTATGCAATTAGGTAAGTACG

pLAK5
EAW58
EAW173

CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC
AGAGTT(ACG)CATAAC*CTCTTGTAAG
ATGGGCGTTG
14

Table 3 (continued): Primers used in this study
Tm
(°C)

DNA
Template

R

57.0

ST279

F

57.2

ST279

Direction

Tm
(°C)

Template

GTCGTTCAGATTGCGCTTTACTACC
AGTTGATTCATCAGATGAGGTTGTC
GGTAGCTAGCAGACTATAAATGGAG
GTATATCTCATGGAAG
CTAGCTAATGTTACGTTACACATTAAC
TAG AC
CCCTGATGGTCGTCATCTACCTG

F
F

57.9
54.9

pLAK1
pLAK1

F

56.1

pLAK1

F

55.3

pLAK1

R
pLAK2/pLAK3/pLAK4/pLAK5

58.7

pLAK1

GTCGTTCAGATTGCGCTTTACTACC

F

57.9

EAW24

ACG AAG ATG GCA CAC CTG

F

55.2

EAW26

AGTTGATTCATCAGATGAGGTTGTC

F

54.9

TTACAA(CGT)GTTATG*GAAAACTCTA
AAATTATGCAATTAGGTAAGTACG

F

57.9

AAAAGGAAGGGCTGTGTTC

F

57.0

R

58.1

ST247

F

56.1

ST247

F

55.2

ST247

F

55.2

ST361

F

59.2

ST361

F

57.3

ST361

Primer

EAW61
EAW174

Sequence (5’-3’)
Direction
Plasmid Construction Primers
pLAK5
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC
GTTATG(CGT)AACTCT*AAAATTATGC
AATTAGGTAAGTACGAACC

Sequencing primers
Primer
EAW1
EAW26
PKD101
pMADSF
pMADSR
EAW1

EAW172
SMT46

Sequence (5’-3’)
pLAK1

pLAK2/pLAK3
pLAK4/pLAK5
pLAK2/pLAK3
pLAK4/pLAK5
pLAK2/pLAK3
pLAK4/pLAK5
pLAK2/pLAK3
pLAK4/pLAK5
pLAK2/pLAK3
pLAK4/pLAK5

ST247
EAW6
EAW7
EAW24

AATAATT(T)TTTTTTG*TCTAGCTATTT
CAGCTAAGTTTTGCG
CAAAAAA(A)AATTATT*AAAAATTAAC
GGAGGCATTTAAATGGAAC
ACG AAG ATG GCA CAC CTG

ST361
EAW24
GC47FA3
PKD47

ACG AAG ATG GCA CAC CTG
TGCGAGTAACAATGTTAAACCGCAAG
T
AGAATGAGTTAAAGCGAGATGTGAAA
AGCGGTGATTGATTTAAAAGTAAAGT
TT

Annealing sequence is underlined. Tm corresponds to annealing sequence.
Restriction cuts marked with asterisk. Mutations in parentheses (XXX).
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microwaved, cap open, on “High” for 90 seconds, and thoroughly vortexed with 10 µl of
HPLC grade water.

2.4 Agarose Gel Electrophoresis
Analytical and preparatory agarose gels were prepared to assess if PCR reactions
were successful, prepare enzymatic restriction digests for gel purification, and to verify
insertions or deletions of gene products in vectors. 0.6% and 1% agarose (KSE Scientific;
Durham, NC) gels were prepared with 1X Tris-acetate-EDTA (TAE) buffer and 0.3 µg/ml
ethidium bromide.
Samples for analytical gels were prepared in the following manner: 1 µl of 6X
loading dye (50% v/v glycerol, 50% v/v 1X TAE, bromophenol blue added to desired color)
was thoroughly mixed with 2 µl of the appropriate ladder, either Hyperladder I or
Hyperladder IV (both supplied by Bioline; Taunton, MA). 1 µl of 6X loading dye was
thoroughly mixed with 2 µl of sample to be analyzed and loaded into 1% agarose gels
and electrophoresed in 1X TAE buffer at 115V for approximately 50 minutes, or until
ladder bands were easily visualized.
Samples for preparatory gels were prepared in the following manner: 1 µl of 6X
loading dye was thoroughly mixed with 2 µl of the appropriate ladder, either Hyperladder
I or Hyperladder IV. For larger volumes, the loading dye was scaled up as follows: 25 µl
6X loading dye was added to 150 µl PCR reactions or enzymatic restriction digests. For
gel purifications, the entire sample plus the appropriate amount of loading dye was loaded
into a single, large lane on the gel and electrophoresed in 1X TAE at 115V until ladder
bands were easily visualized.
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Following electrophoresis, all gels were examined on a White/UV transilluminator
(VWR; Randor, PA) and photographed using a Fotodyne FOTO/Analyst Apprentice - UV
system (Heartland, WI) with a Canon Powershot S100 (Melville, NY) camera. Gel images
were edited using Adobe Photoshop in a standardized manner: all gels were converted
to grayscale and the auto-levels feature was used, without any additional manipulation,
as needed.

2.5 Construction of Plasmids
Plasmids were constructed through PCR amplification of the desired insert, vector
preparation (including PCR purification, restriction enzyme digestion, and gel extraction),
In-Fusion® reaction and final confirmation of the construct through Sanger sequencing.
In-Fusion® reactions were generally performed as follows: ~60 ng of restriction enzyme
digested vector, no less than 20 ng of insert DNA, and 2 µl of 5X In-Fusion® HD Enzyme
Premix were brought to a final reaction volume of 10 µl with HPLC-grade water. The
reaction mixture was incubated in a 50°C water-bath for 15 minutes and then placed on
ice. The reaction was either stored at -20°C or used to transform competent cells. Vector
control reactions were performed side-by-side, without the addition of the desired insert
DNA.

2.6 Transformation of E. coli
In order to propagate newly constructed plasmids, Stellar™ competent E. coli cells
(Clontech Laboratories Inc., Mountain View, CA) were transformed with the plasmids.
One 50 µl aliquot of competent cells was thawed on ice before being pipetted into a sterile
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15 ml conical tube containing 2.5 µl of the final In-Fusion® reaction mixture. The reaction
mixture was incubated on ice for 30 minutes before being heat-shocked in a 42°C waterbath for 45 seconds and immediately placed on ice. After 2 minutes, 450 µl of SOC
medium (Clontech Inc.; Mountainview, CA) was added to the reaction and it was then
incubated for 1 hour at 37°C on an orbital shaker set to 200 rpm. After the hour long
incubation, 5 µl and 100 µl of the transformation mixture were spread onto LB plates
supplemented with 100 µg/ml ampicillin. The remaining volume of the transformation was
aseptically transferred to a sterile 1.5 ml microcentrifuge tube and pelleted for 3.5 minutes
at 4000 rpm. The supernatant was decanted and the pellet was re-suspended in the
residual media by vortexing and the concentrate was also plated on the appropriate
media. The vector control In-Fusion® reaction transformation was performed side-by-side
and 100 µl of the transformation reaction was plated. All plates were incubated at 37°C
for 24 hours.

2.7 S. aureus Competent Cell Preparation (Nickoloff, 1995)
To prepare electrocompetent S. aureus cells, the desired strain was first grown
overnight in TSB at 37°C with 200 rpm shaking. In a sterile Klett flask, 100 ml of fresh
TSB was inoculated with 1 ml of the desired strain overnight culture. The culture was
shaken at 37°C with 200 rpm shaking for approximately 3 hours, until Klett=95
(OD600=0.5) was reached. The Klett flask was immediately transferred to ice for 15
minutes to suspend bacterial growth. The culture was split between two 50 ml conical
tubes, kept on ice at all times, and both were pelleted at 4°C for 15 minutes at 4000 rpm.
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The supernatant was decanted and each cell pellet was re-suspended and washed with
15 ml ice-cold, sterile Milli-Q (EMD Millipore; Darmstadt, Germany) water before being
re-pelleted at 4°C for 15 minutes at 4000 rpm. The wash step was repeated 2 more times
for a total of 3 wash steps. Each cell pellet was then washed with 30 ml ice-cold sterile
10% glycerol and allowed to sit at room temperature for 15 minutes. The cells were
pelleted at 4°C for 5 minutes at 4000 rpm and the supernatant was decanted. Each pellet
was re-suspended in 300 µl of 10% ice-cold glycerol. The re-suspended cells were
aliquoted (60 µl) and stored at -80°C.

2.8 Transformation of S. aureus
S. aureus electrocompetent cells (all RN4220 derivatives) were transformed by
electroporation. One 60 µl aliquot of the desired electrocompetent cells was thawed on
ice and 6 µl (0.3-0.6 µg) plasmid DNA were added to the thawed cells and allowed to sit
for 30 minutes on ice. Pipette tips and cuvettes were kept at -20°C prior to being used.
The reaction mixture was transferred to a 0.1 cm Gene Pulser® cuvette and
electroporated on the STA setting (2.50 kV for 1 pulse, 2.5 ms) of a MicroPulser™
electroporation apparatus. Immediately after the pulse, 0.7 ml of brain heart infusion broth
(BHI) was added directly to the cuvette and the cells were transferred to a 2 ml
microcentrifuge tube containing an additional 0.3 ml BHI. Cells recovered by shaking at
32°C and 200 rpm for 2 hours. Cells were plated on TSA plates supplemented with
appropriate antibiotics and/or X-gal, as needed. Generally, 5 µl, 100 µl and the cell pellet
concentrate (pelleted at 4000 rpm for 3 minutes, supernatant decanted, pellet re-
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suspended in residual supernatant) were spread and incubated for 48 hours at 32°C.

2.9 Allelic Exchange
S. aureus strains carrying derivatives of the pMAD allelic exchange vector were
selected by plating on TSA plates supplemented with erythromycin (5 µg/ml) and X-gal
(200 µg/ml) and incubated overnight at a permissive growth temperature, 32°C. Blue
candidate colonies were chosen. TSB (2 ml) supplemented with erythromycin (5 µg/ml)
was inoculated with a single colony and shaken overnight in a 42°C water-bath, which is
a non-permissive growth temperature for the pMAD plasmid. Selection for antibiotic
resistance at this temperature yields cells in which there has been homologous
recombination of the plasmid carrying the desired mutation into the gene of interest in the
S. aureus chromosome, yielding a cointegrate. All experiments were performed in
quadruplicate. Samples were subcultured into 2 ml fresh TSB supplemented with
erythromycin (5 µg/ml) and shaken overnight in a 42°C water-bath. This step was
repeated a third time. The cultures were then 10-fold serially diluted to 10-5 and 100 µl
were spread on TSA plates supplemented with erythromycin (5 µg/ml) and X-gal (200
µg/ml) and incubated overnight at 42°C. Blue cointegrate colonies were chosen. TSB (5
ml) was inoculated with one blue colony and shaken overnight at 200 rpm at 30°C, a
permissive temperature that encourages plasmid resolution. This step was repeated
before samples were subcultured into 2 ml fresh TSB and shaken overnight at 42°C. This
step was repeated twice. The cultures were 10-fold serially diluted to 10-5 and 100 µl was
spread on TSA plates supplemented with X-gal (200 µg/ml). Plates were incubated for 48
hours at 30°C. White colonies were patched onto TSA plates supplemented with
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erythromycin (5 µg/ml) and X-gal (200 µg/ml) and onto TSA plates supplemented with
only X-gal (200 µg/ml), in that order. Plates were incubated overnight at 30°C. White
erythromycin-sensitive candidate colonies/patches that resolved the cointegrate and the
plasmid were picked and plated on TSA plates supplemented with X-gal (200 µg/ml).
Plates were incubated for 24-48 hours at 30°C. Candidate colonies were screened via
colony PCR to ensure that the desired insert had homologously recombined and resolved
and that the isolated candidate colony was not carrying an empty vector. After PCR
screening, PCR clean-ups were performed using the QIAquick PCR Purification Kit
(Qiagen; Valencia, CA), and allelic exchange candidates were verified by Sanger
sequencing through Eurofins MWG Operon.

2.10 Phage Propagation: Inductions
Lysogenic staphylococcal strains were induced in order to generate bacteriophage
80α phage lysates. Inductions were performed either through UV irradiation or the use of
mitomycin C (MC). Both methods take advantage of the SOS response pathway which
occurs in direct response to cellular DNA damage. Ten milliliters of a 25:1 solution of CY
+ GL media were inoculated with 50-100 µl of fresh overnight culture of the desired
lysogenic S. aureus strain. CY media is a preparation of 1% wt/vol casamino acids, 1%
wt/vol yeast extract, 0.5% wt/vol glucose, 0.59% wt/vol NaCl (Novick, 1991). GL media is
composed of 0.6 M β-glycerophasphate disodium salt pentrahydrate. Cell density was
measured using a Klett-Summerson colorimeter until the starting cell density was
approximately 10% of the final desired cell density. Cultures were grown at 30°C with 200
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rpm shaking and cell density was monitored for several hours until the appropriate cell
density was reached. For induction by UV irradiation, the final cell density was
approximately Klett=95 or OD600=0.6, while cultures for MC induction were grown to
Klett=30 or OD600=0.3.
For MC induction, equal volumes of SA phage buffer (Novick, 1991) (1 mM MgSO4,
4 mM CaCl2, 2.5 M Tris-HCl pH 7.8, 100 mM NaCl, 0.1% gelatin) and CY + GL media
were combined. One milliliter of the Klett=100 culture was added to 9 ml CY + GL/ SA
phage buffer. Two microgram per milliliter of MC was added to the culture mixture and
then grown at 30°C with reduced shaking, 100 rpm, for approximately 2 hours or until cell
lysis. Lysates were filter sterilized using a 0.22 µm syringe filter and stored at 4°C.
For UV induction, cultures were grown to Klett=30. Cultures were aseptically
transferred to 15 ml conical tubes and centrifuged for 10 minutes at 4000 rpm at 4°C. The
supernatant was discarded and the pellet was re-suspended in 5 ml of SA phage buffer.
A conical tube containing 5 ml CY + GL buffer was prepared and set aside. The resuspended cell pellet was transferred to a sterile petri dish, avoiding bubble formation. In
a Nuaire Biological Safety Cabinet - Class II, Type A/B, equipped with a Philips TUV
15W/G15 Longlife bulb, the petri dish was placed on a rocker, the lid removed, and
exposed to UV light for 20 seconds. The distance from the plate rocker to the UV bulb
was approximately 57.8 cm. The prepared 5 ml CY + GL media was added immediately
to the petri dish. The petri dish contents were transferred to a new, sterile Klett flask and
incubated at 30°C with reduced shaking, 100 rpm, for approximately 2 hours or until cell
lysis. Lysates were filter sterilized using a 0.22 µm syringe filter (Millipore; Billerica, MA)
and stored at 4°C.
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2.11 Bacteriophage Titering Assay
All titering assays were performed in triplicate. Five milliliter cultures of S. aureus
RN4220 were grown overnight at 37°C in TSB with 200 rpm orbital shaking. Lysate
dilutions were prepared as follows for both the control strain (RN10616) and the strain to
be tested: 10-2, 10-3, 10-4, 10-6, 10-7, and 10-8 dilutions of phage lysate in SA phage buffer.
One hundred-fold dilutions were made by diluting 10 µl of lysate into 990 µl SA phage
buffer. Ten-fold dilutions were made by diluting 100 µl of lysate into 900 µl SA phage
buffer.
Top agar aliquots were prepared by mixing 3 ml of top agar with 30 µl of 0.5 M
CaCl2 (final concentration of 5 mM) and incubating at 65°C immediately prior to use.
Phage top agar is composed of 0.3% wt/vol casamino acids, 0.3% wt/vol yeast extract,
100 mM NaCl, 0.75% wt/vol agar, pH 7.8 (Novick, 1991). One hundred microliters of the
phage lysate dilution was mixed with 100 µl of the RN4220 overnight culture and allowed
to adsorb for 3 minutes at room temperature. After adsorption, the top agar mixture was
added to the 200 µl phage:RN4220 mixture and immediately poured onto phage agar
plates and allowed to solidify at room temperature. Phage agar plates are composed of
0.3% wt/vol casamino acids, 0.3% wt/vol yeast extract, 100 mM NaCl, 1.5% wt/vol agar,
pH 7.8 with 5 mM CaCl2 added after media was autoclaved (Novick, 1991). Phage agar
plates were incubated at 32°C for 24 hours before plaques were counted. Plaque forming
units were calculated using the following equation:

PFU number of plaques
=
ml
(d x v)
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Where, d = dilution of plate counted
v = volume of lysate dilution plated

2.12 SaPI1 Transductant Titering Assay
The quantification of SaPI1 transductants was accomplished through a modified
phage-titer protocol, as described above. All SaPI derivatives used in this study contain
a tetM cassette. As a result, SaPI1 strains were selected by plating on GL plates
supplemented with 5 µg/ml tetracycline. Serial dilutions were made following the phagetiter assay protocol: 100 µl of lysate dilution was mixed with 100 µl of RN4220 culture and
allowed to adsorb at room temperature for 5 minutes. The 200 µl lysate dilution:RN4220
mixture was poured onto GL-tet plates and allowed to solidify at room temperature before
being incubated for 24-48 hours at 32°C. SaPI1 colonies or transducing units (TU) were
calculated using the following equation:

TU number of plaques
=
ml
(d x v)

Where, d = dilution of plate counted
v = volume of lysate dilution plated

2.13 Plaque Purification Assay
In order to isolate plaques for further analysis, individual plaques were cored from
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the titer plates using a flame sterilized Pasteur pipette and expelled into a 1.5 ml
microcentrifuge tube containing 1 ml of SA phage buffer. The agar core was allowed to
stand at room temperature for 15 minutes before being serially diluted as follows: 10 0,
10-1, 10-2, 10-3 and 10-4. Dilutions were prepared and plated, following the standard phage
titering assay: 3 ml of top agar, supplemented with 30 µl of 0.5 M CaCl2, were prepared
and kept at 65°C prior to use. One-hundred microliters of an overnight culture of RN4220
were mixed with 100 µl of each lysate dilution and the phage were allowed to adsorb for
3 minutes at room temperature. The supplemented top agar was added to the phage
dilution-cell mixture and immediately plated on phage agar. Plates were allowed to solidify
at room temperature before being incubated for 24 hours at 32°C. Purified plaques were
then cored and expelled into 1 ml HPLC-grade water. One microliter was used as the
template to perform PCR amplifications of the mutant strain in order to confirm the
mutation through Sanger sequencing.

2.14 Data Analysis
All titer assay data were analyzed in GraphPad Prism® (La Jolla, CA). Raw data
were organized in Microsoft® Excel® 2013 (Redmond, WA) and phage titers were
calculated in PFU/ml. The phage titers were then imported into GraphPad Prism® and
graphed. Phage titer assays were performed in biological and technical triplicate and all
significant results were averaged and standard deviation was calculated.
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Chapter 3
Investigation of the interface between 80α scaffold and major capsid proteins

Introduction
Bacteriophage virion assembly begins with the formation of a transient procapsid,
which eventually expands to form a mature virion. Procapsid assembly is important
because without a properly formed procapsid, the subsequent capsid assembly steps will
not occur, preventing the formation of viable phage progeny. The procapsid is an empty
precursor particle that is comprised primarily of scaffold and capsid proteins. In addition,
a portal protein and an uncharacterized minor capsid protein are involved in 80α
procapsid assembly. Scaffolding proteins act as a catalyst for procapsid formation by
serving as molecular chaperones for the major capsid protein, leading to the nucleation
of the major capsid proteins and eventual procapsid formation (Dokland, 1999). While this
protein:protein interaction is critical to capsid assembly, little is known about the specific
way in which 80α scaffold and capsid interact. In the case of 80α, the major capsid protein
also interacts with the SaPI1-encoded alternative scaffolding protein, CpmB. These two
capsid assembly pathways provide a unique model for the study of scaffold:capsid
interaction.
The likely contacts between SaPI1 scaffold CpmB and 80α capsid protein gp47
were mapped by a previous genetic study carried out in our lab. The two SaP1-encoded
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capsid size redirection genes, cpmA and cpmB, were introduced into the capsid
morphogenesis gene cluster of an 80α prophage between gp44 (minor capsid protein)
and gp46 (scaffold). This was lethal to lytic growth of the phage, because only small
capsids that are unable to accommodate the larger phage genome were formed. This
provided a strong selection for lthe oss of ability to form small capsids, as such mutants
would restore phage growth. Rare viable phage plaques were isolated that restored the
ability to form large capsids (E.A. Wall, unpublished). These mutants either carried
deletions of cpmA and cpmB or point mutations in cpmB. Those in cpmB mapped to two
regions, one being the dimer interface and the other being the very C-terminal end of the
protein (Figure 3). While the SaPI1 scaffold and 80α scaffold proteins are very different
in size and share little overall amino acid similarity, there is a striking conservation of
residues at their C-termini, particularly the RIIK motif where the cpmB mutations were
found. This suggested that both scaffolds are interacting with the phage capsid protein in
a similar way, likely involving the same region of capsid. Two questions were posed based
on these results: (1) will these C-terminal scaffold mutations found in SaPI1 have the
same effect if they are introduced into the 80α scaffold protein? (2) Can we use these
mutations in scaffold to isolate compensatory capsid mutations that would help identify
where and how gp46 interacts with gp47?

Compensatory 80α capsid mutations
The C-terminal point mutations that prevented small capsid formation in SaPI1
CpmB were R69S, R69K, and I70T (Figure 3; E.A. Wall, unpublished). Our strategy was
to introduce similar mutations into the C-terminus of phage scaffold and then try to isolate
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Figure 3: Alignment of the C-termini of SaPI1 CpmB and 80α gp46
Four C-terminal residues in the alternate SaPI1 scaffold protein, CpmB, and 80α scaffold
protein, gp46, RIIK, are highly conserved. Not shown here are SaPI2 and SaPI3, which
also contain conserved RIIK residues in their alternate scaffold proteins. The red arrows
indicate rare compensatory mutations found in CpmB, following the expression of CpmA
and CpmB in 80α, and the corresponding mutations subsequently introduced into the Cterminus of 80α scaffold.
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spontaneous compensatory mutants in capsid. Because a single point mutation has a 1
in 106 likelihood of occurring spontaneously, all of our mutations were made using 2
nucleotide changes that would naturally occur at a rate of 1 in 10 12. Since the standard
80α lysate after prophage induction has a titer of approximately 1010 PFU/ml,
spontaneous revertants of the change in scaffold should be well below the limit of
detection. The arginine to lysine mutation was not used in this study as there is no lysine
codon that can be substituted that cannot revert to arginine by a single nucleotide change.
Instead, the arginine was replaced independently with a glutamic acid and a serine. The
serine and glutamic acid point mutations were introduced into an 80α lysogen, resulting
in R202S and R202E. It was predicted that the introduction of these point mutations into
this highly conserved region of 80α scaffold protein would force compensatory mutations
in capsid that would re-establish the scaffold-capsid interface and therefore allow the
production of viable phage. When these mutations were introduced, R202E and R202S
were both lethal to the phage, as expected, underscoring the importance of the highly
conserved C-terminal region of scaffold.
Unfortunately, neither point mutation at residue 202 in 80α scaffold generated any
spontaneous compensatory mutations. We next examined the effect of mutations
introduced at residue 203, equivalent to CpmB residue 70. The same I to T mutation that
inactivated CpmB was introduced into 80α scaffold, resulting in a new 80α lysogen
carrying gp46 I203T. Upon UV induction and plaque titering, viable plaques were
recovered at a low frequency (Figure 4). After plaque purification, several mutant
candidates were sequenced to determine the nature of the mutations. Three distinct
compensatory mutations were found in 80α capsid: M52I, M52L, and Y123C.
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Figure 4: Representative effect of gp46 I203T mutation on 80a phage titer.
Wildtype 80α (RN10616) and 80α gp46 I203T (ST358) strains were grown to midexponential phase before being induced with 2 µg/ml of mitomycin C. The I203T scaffold
mutants that formed plaques also contained compensatory capsid mutations.
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Effect of C-terminal scaffold mutations on SaPI1
Although SaPI1 CpmB acts as an alternate scaffold, the phage scaffold protein is
still required. We predicted that another part of the larger phage scaffolding protein
provided this “other” function, and that the presence of SaPI1 scaffold would substitute
for the phage scaffold RIIK capsid interaction during formation of small procapsids.
Therefore, we examined the effects of C-terminal 80α scaffold mutations on SaPI1
transduction. Three separate 80α lysogens containing mutations in the conserved Cterminal residues of scaffold, specifically R202E, R202S, and I203T, were transduced
with SaPI1. When the original 80α strains were induced and titered, as discussed above,
all three resulted in a lethal phage phenotype. The strain encoding the I203T mutation in
scaffold did result in the low level production of rare compensatory capsid mutations. The
80α prophage in these SaPI1 transductions was induced, and both the phage and SaPI1
titers were determined. No SaPI1 transducing particles were recovered from either of the
point mutations at residue 202. However, when the strain carrying the I203T mutant was
induced and titered, SaPI1 transduction appeared to be normal. While these are
preliminary results, they are notable as they indicate the SaPI1 scaffold does not simply
replace the C-terminal contacts made by the phage scaffolding protein. The different
behavior of the R202 mutants and the I203T mutant in supporting SaPI1 growth is not
currently understood.

Identifying the specific scaffold and capsid interface
Based upon a structural model of the SaPI1 scaffold CpmB mapped onto cryo-EM
densities of the SaPI1 procapsid, (Dearborn et al., 2012), it appeared that an alpha-helix
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of the C-terminal end of scaffold and an alpha-helix near the N-terminus of capsid formed
a parallel interface. The compensatory mutations M52I and M52L map to a residue within
a predicted alpha-helix near the N-terminus of capsid. This residue is flanked by two
glutamic acids at residues 50-53 (EVME). This led to the hypothesis that the conserved
and critical C-terminal R202 residue in scaffold could interact with and possibly form a
salt-bridge with one of the glutamic acid residues in 80α capsid (Figure 5). The protein
stabilization created by the interaction of the guanidinium group of arginine and the side
chain carboxyl of glutamic acid would contribute to maintenance of the proper alphahelical interaction between scaffold and capsid (Figure 6). Recently, Cortines et al. have
shown that a specific salt-bridge interaction between the C-terminal scaffold residue R293
and the N-terminal capsid residue D14 in bacteriophage P22 is enough to establish the
proper protein:protein interaction for successful procapsid assembly.
To test the hypothesis that R202 interacts with E50 or E53, four new strains
containing 80α prophages with scaffold and capsid mutations were constructed: gp47
E50R (ST375), gp47 E53R (ST376), gp46 R202E + gp47 E50R (ST377), and gp46
R202E + gp47 E53R (ST378). The prediction was that at least one of the capsid
mutations, E50R or E53R, would be lethal, due to the inability to form a salt bridge with
R202. The R202E scaffold mutation, on its own, is lethal. However, if the salt-bridge
interaction was occurring at the proposed residues, then it was anticipated that the
simultaneous replacement of R with E in scaffold and E with R in capsid would lead to the
re-establishment of the salt-bridge interaction and rescue the lethal R202E scaffold
phenotype, resulting in viable progeny phage. All four strains were induced using MC,
and plaque titer assays were performed. Surprisingly, both single capsid mutant strains,
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Figure 5: Predicted secondary structure of the hypothesized alpha-helical interaction site between gp46 (scaffold
protein) and gp47 (major capsid protein).
The predicted secondary structures of gp46, scaffold protein, and gp47, major capsid protein. The PSIPRED v3.3 Protein
Sequence Analysis Workbench was used to generate predicted secondary structure.
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Figure 6: Schematic of the proposed salt-bridge interaction between R202 in gp46
and either E50 or E53 in gp47.
The non-covalent protein-protein interactions established by the salt-bridge between
R202 and E50 or E53 may be enough to establish the proper helical interface for
successful procapsid assembly.
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ST375 and ST376, behaved like wild-type 80α, indicating that neither glutamic acid in
capsid was essential or specifically interacting in a critical way with the arginine in scaffold
(Figure 7). Similarly, both of the double phage mutants remained non-viable (Figure 8).
This indicates that the predicted salt bridge contact between R202 in phage scaffold, and
either E50 or E53 in phage capsid, was incorrect.

Discussion
Mutations in the C-terminal end of scaffold gave rise to compensatory mutations,
M52I and M52L, within the predicted alpha-helix in phage capsid, indicating that this
region of capsid does make contact with the scaffold C-terminus. However, the predicted
salt bridge interaction involving one of the flanking glutamic acid residues was not ruled
out by this study. The lethality of the R to K substitution in scaffold still argues strongly for
a salt bridge interaction. Recent studies have indicated that single amino acid salt-bridge
interactions are able to sustain proper protein:protein interaction for successful procapsid
assembly in a similar way to our current model. The C-terminal domain of the P22
scaffolding protein is alpha-helical, which is comparable to the predicted C-terminal alphahelix of the 80α scaffold protein. Again, similar to our model, the N-terminal alpha-helix of
the major capsid protein of P22 is thought to interact with the N-terminal region of scaffold
(Cortines et al. 2014). However, Cortines et al. also indicated other nearby amino acids
that played a stabilizing role in the salt-bridge interaction between the major capsid
protein and scaffold protein of P22, but were not essential. It seems likely, therefore, that
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Figure 7: Effect of E50R and E53R gp47 major capsid protein mutations on 80α
phage titer.
Strains lysogenic for wild type 80α (RN10616), 80α gp47 E50R (ST375) and 80α gp47
E53R (ST376) were grown to mid-exponential phase before being induced with 2 µg/ml
of mitomycin C. Each bar is the result of 3 independent experiments, and the error bars
indicate standard deviation.
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Figure 8: Effect of E50R and E53R gp47 major capsid protein mutations paired with
an R202E gp46 scaffold mutation on 80α phage titer.
Strains lysogenic for wild-type 80α (RN10616), 80α R202E (ST279), 80α gp46 R202E +
gp47 E50R (ST377), and 80α gp46 R202E + gp47 E53R (ST378) were grown to midexponential phase before being induced with 2 µg/ml of mitomycin C. Each bar is the
result of 3 independent experiments, and the error bars indicate standard deviation.
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there is a salt bridge interaction involving a different E or D residue located near this helix
in the 3-D structure of capsid that remains to be identified.
Of note is the third compensatory capsid mutation that was isolated from the
scaffold I203T mutant strain: Y123C. In 80α capsid, there is an integral proline at residue
132 in the procapsid. This proline forms a kink in the α-helix and allows the structural
rearrangement that accompanies a conformational switch necessary for expansion of the
procapsid to the mature capsid (Spilman et al., 2011). Based on an I-TASSER model of
80α capsid mapped onto the HK97 fold, Y123 is predicted to be on the same alpha-helix
as P132. At this time, the biological implications of this compensatory mutation have not
been fully examined.
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Chapter 4

The role of N-terminal cleavage of scaffold and major capsid proteins in
staphylococcal phage 80α and SaPI1

Introduction
Unlike other bacteriophages characterized to date, 80α does not encode a prohead
protease, but rather uses a host-encoded protease for N-terminal cleavage of both its
scaffold (gp46) and major capsid (gp47) proteins (Spilman et al., 2012). When the genes
encoding gp46 and gp47 were cloned into an E. coli expression vector and expressed,
neither protein was cleaved. However, when gp46 and gp47 were coexpressed in S.
aureus, both proteins underwent proteolytic processing to a cleaved form (Spilman et al.,
2012), identical to those found in mature virions (Poliakov et al., 2008). The host-encoded
protease responsible for the N-terminal cleavage of scaffold and capsid was recently
identified as the phage-related ribosomal cysteine protease, Prp (Wall et al., 2015). Prp
removes the first 13 amino acids from gp46 and the first 14 from gp47 by cleaving
between phenylalanine and alanine in a conserved motif. Capsid cleavage apparently
occurs even in the absence of capsid assembly. Therefore, we wanted to investigate the
requirements for scaffold and capsid cleavage in the assembly of both phage and SaPI
capsids.
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N-terminal cleavage of scaffold
A mutant allele of the scaffold gene expressing the cleaved version of the protein
(accomplished by deletion of amino acids 2-13) was introduced into an 80α prophage
through allelic exchange to generate strain ST247. The “precleaved” 80α (gp46∆2-13)
lysogen was induced by UV irradiation and titered following the standard plaque assay.
No viable phage were recovered (Figure 9).
Previous studies have demonstrated that scaffold is essential for formation of 80α
capsids. Strain ST91, an 80α lysogen in which orf46 has been deleted, was induced, and
the resulting lysate was purified and examined via electron microscopy (EM) (Spilman et
al., 2012). Experiments replicating this result and comparing it to the structures
assembled after induction of the pre-cleaved scaffold mutant in ST247 were performed
by Keith Manning in Dr. Terje Dokland’s lab (Figure 10). As can be seen in Figure 10,
both the complete deletion of gp46 and the pre-cleaved form of gp46 result in strikingly
similar phenotypes. While the characteristic non-contractile tails and baseplates of 80α
were observed, no procapsids or mature capsids were seen. This indicates that the
cleavage of gp46 is essential and that improper regulation or timing of cleavage is as
detrimental to 80α as the complete absence of scaffold.

Effect of scaffold mutations on SaPI1
80α capsid is unique in its ability to interact with not only its own native phage
scaffold, but also the alternate scaffold formed by SaPI1. However, the SaPI1-encoded
alternate scaffold is unable to substitute completely for phage scaffold (Spilman et al.,
2012). Therefore, we wanted to examine the role of scaffold cleavage in formation of
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Figure 9: Effect of N-terminally cleaved scaffold on 80α titer.

Strains carrying prophage of wild-type 80α (RN10616) and 80α with N-terminally cleaved
gp46 ∆2-13 (ST247) were grown to mid-exponential phase before being induced with 2
µg/ml of mitomycin C, and the resulting lysates were titered on RN4220. Each bar is the
result of 3 independent experiments, and the error bars indicate standard deviation.
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A

Figure 10: Electron micrographs of CsCl purified 80α phage structures from
scaffold mutants.
EMs used with permission of Dr. Terje Dokland. Scale bar indicates 100 nm. Phage
suspensions for negative stain were applied to glow-discharged carbon-only grids
(Electron Microscopy Sciences), washed twice with dialysis buffer and stained with 1%
uranyl acetate. Samples were observed in an FEI Tecnai F20 electron microscope
operated at 200kV. Images were captured on a 4k x 4k Gatan Ultrascan CCD camera.
(A) EM of structures formed by induction of an 80α lysogen encoding pre-cleaved scaffold
(ST247).
(B) EM of structures formed induction of an 80α lysogen encoding scaffold deletion
(ST91). White arrows indicate possible portal structures, not procapsids.
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SapI1 transducing particles. SaPI tst:tetM was introduced by transduction into the strain
carrying the 80α (gp46∆2-13) prophage to yield strain ST365. The resulting lysate was
titered for SaPI1 transducing particles following UV induction. While this experiment has
only been carried out once thus far and must be considered preliminary, SaPI1 was able
to transduce effectively.
Additionally, we wanted to examine the effects of C-terminal 80α scaffold
mutations on SaPI1 transduction. In particular, we wanted to test whether the wild-type
SaPI1 alternate scaffold could substitute for phage scaffold that was defective in the
similar C-terminal contacts with capsid. SaPI1 was transduced into an 80α lysogen
containing mutations in the conserved C-terminal residues of scaffold, specifically R202E,
R202S, and I203T, resulting in the following strains: ST366 (80α gp46 R202S), ST367
(80α gp46 R202E), and ST368 (80α gp46 I203T). As described in Chapter 3, all three of
these mutations prevented 80α plaque formation, and the I203T mutation gave rise to
rare compensatory capsid mutants. When the strains carrying mutant R202E and R202S
prophages plus SaPI1, were induced and titered, no SaPI1 transducing particles were
recovered. However, when the strain encoding the I203T mutant was induced and titered,
SaPI1 transduction appeared to occur at wild-type levels. These results are notable as
they indicate SaPI1 does not require the N-terminal cleavage of 80α scaffold to transduce
effectively. However, C-terminal point mutations in 80α scaffold, specifically R202E and
R202S, block SaPI1 transduction, demonstrating that SaPI1 does not simply replace the
contacts between the scaffold C-terminus and the capsid N-terminus with its own scaffoldcapsid interaction. The difference between the results obtained with the R202 mutants
and the I203T mutant remains to be explained.
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Effect of uncleavable capsid on 80α growth
The role of capsid cleavage in 80α was investigated by introducing the mutation
F14A into the cleavage motif. This prevents cleavage of the capsid protein. This mutant
allele was introduced into an 80α prophage and assayed for plaque formation following
UV induction. Surprisingly, this mutation resulted in viable phage with a titer that was not
significantly different from wild-type titer (Figure 11). While N-terminal cleavage of scaffold
is essential for the production of viable phage virions, cleavage of the capsid protein is
not essential for proper capsid formation.
The result with uncleavable capsid has been confirmed in a slightly different
background, RN450. Our uncleavable capsid strain, ST361, was constructed in the strain
RN4220. RN4220 is a restriction-minus derivative strain of RN450 (Novick, 1967;
Kreiswirth et al. 1983). Strain ST208, which also contains a prophage with uncleavable
capsid (gp47 F14A) is in the RN450 background. Figure 12 presents unpublished data
from our collaborator’s lab of cryo-EM images obtained after the induction and purification
of ST208 lysates. Both wild-type 80α and uncleavable capsid are strikingly similar in their
mature capsid formation, providing further evidence that the cleavage of major capsid
protein is not required for phage viability. Furthermore, 3-D reconstruction of the cryo-EM
images display extra density on the outside of the capsids, attributable to the extended
N-terminal residues (data not shown).

Discussion
These data indicate that the cleavage of gp46 during assembly is an essential
process in the formation of phage capsids. It is hypothesized that the N-terminal tail of
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Figure 11: Effect of uncleavable capsid protein, gp47, on 80α phage titer.
Strain carrying lysogens of wild-type 80α (RN10616) and 80α gp47 F14A (ST361),
uncleavable capsid protein, strains were grown to mid-exponential phase before being
induced with 2 µg/ml of mitomycin C and titered on RN4220. Each bar is the result of 3
independent experiments, and the error bars indicate standard deviation.
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B

A

Figure 12: Cryo-EM of capsid formation in wild-type 80α (A) and uncleavable capsid
(gp47 F14A) (B).
EMs used with permission of Dr. Terje Dokland. Samples of purified phage lysate were
applied to C-flat holey film (Electron Microscopy Sciences), flash frozen, transferred to a
Gatan 626 cryo-specimen holder and visualized in an FEI Tecnai F20 electron
microscope operated at 200 kV at a magnification of 81,200x.
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scaffold may play a role in stabilization during procapsid formation, as scaffold serves as
a chaperone for the proper accumulation of capsid, and therefore proper procapsid
assembly. Without this interaction, no viable phage progeny are produced. However, this
cleavage event is apparently not required for efficient SaPI1 transduction. SaPI1
transduction by the 80α gp46∆2-13 prophage in ST247 remarkably resulted in viable
transducing particles even though ST247 alone cannot produce viable phage. This
suggests that a SaPI1 gene product, possibly the alternate scaffold, CpmB, can substitute
for this particular function of phage scaffold. The respective roles of SaPI1 and phage
scaffold proteins in assembly of SaPI transducing particles are still not well understood.
Previous experiments determined that deletion of 80α gp46 resulted in both dead phage
and no SaPI1 transducing particles, so SaPI1 is clearly dependent on phage scaffold in
some way (Spilman et al., 2012).
One hypothesis for the presence of viable SaPI1 transducing particles is that a
virion structure is formed in the pre-cleaved scaffold mutant but it is unable to produce
viable phage, possibly because it is unable to expand to mature capsid. In that case, the
genome of 80α would not be packaged, but the smaller SaPI1 genome could still be
accommodated. However, the EMs of ST247 do not reveal any procapsid formation,
indicating that SaPI1 must be compensating in some way to allow capsid assembly,
possibly via the alternative scaffold, CpmB. Additionally, if the N-terminus of phage
scaffold is required for Prp binding and chaperone function, maybe SaPI1 CpmA can
function as an alternative chaperone for assembly of the smaller SaPI1 procapsids.
Another possibility would be that full length gp46 is needed for the proper localization of
gp44, the minor capsid protein, in the procapsid in addition to its role as a chaperone
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protein for capsid. Prior work in our lab has demonstrated that gp44 is essential for the
phage, but not for SaPI1.
While cleavage of gp46 is essential, N-terminal cleavage of gp47 is most notably
not. Strain ST361 induction and plaque titering revealed that uncleavable gp47 behaves
similarly to wild-type 80α. This suggests that the extra N-terminal 13 amino acids can be
accommodated in the mature capsid without affecting capsid integrity. This result was
surprising, and raises the question of why the phage has retained the cleavage motif. One
possibility is that Prp functions as a chaperone for assembly in addition to its role as a
protease, and this sequence is required for Prp binding.
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Chapter 5

Discussion

The purpose of this work was to characterize the interactions between
staphylococcal phage 80α scaffold and capsid proteins and their roles in functional capsid
assembly. Capsid assembly is a multi-step, complex process that is predicated by the
proper assembly of a transient procapsid structure. Like all tailed bacteriophages, multiple
copies of the internal scaffolding protein of 80α and the HK97-like major capsid proteins
nucleate and self-assemble into a procapsid structure (Suhanovsky et al., 2015).
Following a dramatic conformational change involving the dynamic “switch” of P132 in
capsid, the procapsid expands, internal scaffold proteins are lost, DNA is packaged, and
external capsid proteins rearrange, finally forming a mature icosahedral capsid that
contains the entire 80α genome (Spilman et al., 2011). Unlike other tailed phages, the
80α capsid assembly process can be hijacked by a mobile genetic element, SaPI1. SaPI1
is able to redirect capsid assembly via two SaPI1 encoded genes, cpmA and cpmB, and
instead of forming large capsids, preferentially forms smaller transducing particles that
package SaPI DNA, in lieu of the 80α genome. Of particular note is the presence of an
alternate SaPI1 scaffold protein, CpmB. It is this unique instance, where two distinct
scaffold proteins interact with the same capsid protein in strikingly similar ways, which
allowed us to explore not only location of the protein:protein interface between scaffold
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and capsid, but also the roles of scaffold and capsid cleavage in the context of 80α and
SaPI1.

Investigating 80α scaffold and capsid protein interactions
It was predicted by our lab that the 80α scaffold and capsid proteins formed a
stable interface through the formation of a non-covalent salt bridge between a C-terminal
R202 residue in scaffold and a glutamic acid in capsid (either residue E50 or E53). This
prediction arose from a structural model, based upon the cryo-EM densities of SaPI1
scaffold, CpmB, mapped onto a SaPI1 procapsid, but also from genetic evidence from
previous work in our lab. This interaction was tested in various ways. First, the predicted
alpha-helix in capsid, containing the EVME motif of interest (residues 50-53), was
mutated separately at two sites, resulting in two single capsid mutant strains carrying an
80α prophage with either an E50R or E53R capsid mutation. If our hypothesis had been
correct, and the arginine-glutamic acid interaction was disrupted by either of these
mutations, the 80α titer would likely have been reduced, if not completely abolished.
However, both strains behaved similarly to wild-type 80α. The next step was introducing
these same capsid mutations into a known lethal phage background, specifically gp46
R202E. In these strains, the hypothesized salt bridge interaction was reversed, with the
glutamic acid of capsid now residing in scaffold, and vice versa. Both double mutant
strains were still non-viable, indicating that the lethal R202E phenotype was unable to be
rescued by a putative re-established salt bridge.
While this region of capsid does appear to directly interact with the C-terminal end
of scaffold, based on the I203T second site suppressor mutants M52I and M52L, it fails
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to establish the predicted salt-bridge interaction. However, there is a very similar motif
nearby at residues 64-67, EPME. These motifs are not identical, however valine and
proline are both non-polar and hydrophobic. While this similar motif is interesting, there
are several issues that need to be resolved. First, when the I203T scaffold mutation was
introduced into 80α, compensatory capsid mutations were found in the predicted helical
region of capsid, at residue 52. Additionally, the EVME motif resides in an alpha-helix,
whereas EPME appears to be in a beta strand, according to the predicted secondary
structure created in PSIPRED. This poses a problem as the conserved residues of
scaffold, RIIK, are also located in an alpha-helix. The long held assumption has been that
scaffold and capsid are interacting via their respective C-terminal and N-terminal alphahelices. An I-TASSER model was constructed where 80α capsid was modeled onto the
HK97-fold (Figure 10). This model appears to conflict with the PSIPRED predicted alphahelical regions of C-terminal scaffold and N-terminal capsid, as they both appear to be
found on beta sheets. However, the I-TASSER model score of -0.6 suggest this model is
not robust. Both the PSIPRED prediction, and the I-TASSER model underscore the need
for an improved structural model of 80α scaffold:capsid interaction. Additionally, the Nterminus of phage scaffold has not been completely modeled, as a result, the EVME
region could lie close to another region that establishes the salt bridge, however, with the
current model this cannot be determined.

Future directions for identifying the interface between scaffold and capsid proteins
While molecular models can be helpful, currently all of these structures are based
on predictions. Previously, our lab has used the bacterial adenylate cyclase two-hybrid
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Figure 13: I-TASSER model of gp46 modeled onto the HK97-fold.
Red indicates glutamic acid residues, yellow indicates methionine, green indicates valine, and pink indicates proline.
The following residues are indicated on the model: EVME (residues 50-53) and EPME (residues 64-67). Geneious 6.1
Bioinformatics software was also used in generating this image.
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system (BACTH) (Euromedex; Souffelweyersheim, France) to investigate the
protein:protein interactions between scaffold and capsid. The BACTH system provides a
much quicker screening tool than our current experimental approach which involves the
very time intensive process of performing allelic exchanges, induction experiments and
plaque titering assays.
The BACTH system is based upon the reconstitution of adenylate cyclase activity
through the interaction of two proteins fused to its fragmented catalytic domain (Karimova
et al., 2000; Battesti et al., 2012). The catalytic domain of adenylate cyclase has two
subdomains that are known to interact with each other, referenced here as T18 and T25.
In the BACTH system used in our lab these two subdomains are inactive when they are
separated. As such, the two subdomains can be fused to two different polypeptides in
order to ascertain whether or not the polypeptides interact with each other. Upon
transformation and coexpression of the two fusion proteins in an E. coli reporter strain
lacking chromosomal adenylate cyclase, the two subdomains can heterodimerize due to
an interaction between the polypeptides being tested, reconstituting the catalytic domain
and resulting in active synthesis of cAMP. The newly synthesized cAMP can go on to bind
the catabolite activator protein, CAP, which then binds to the promoter of the lactose or
maltose operon, inducing gene expression (Battesti et al., 2012). Through this system,
after creating the desired constructs, protein:protein interactions can be visualized
through blue/white screening (β-galactosidase expression is regulated by cAMP/CAP) or
plating on another appropriate indicator media, such as MacConkey agar, which indicates
whether or not maltose is metabolized.
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When the first 90 N-terminal residues of 80α capsid were fused to the T18 fragment
and the last 70 C-terminal residues of 80α scaffold protein were fused to the T25
fragment, the blue/white screening results were inconclusive. It is possible that these
terminal fragments, particularly the N-terminus of capsid, do not assume the proper
conformation. The next step in this process would be to screen the full-length proteins
using the BACTH system, rather than the previously tested polypeptides. Besides the
BACTH system, the more established yeast two-hybrid system could also be used to
approach this problem.

N-terminal cleavage of 80α scaffold and capsid proteins
Previous studies have demonstrated that only cleaved capsid is present in mature
80α virions. Phage scaffold, found in procapsids trapped by a mutation in terminase that
blocks DNA packaging, is also N-terminally cleaved. However, the timing of this cleavage
event is not well defined. Pre-cleaved scaffold and uncleavable capsid both have striking
phenotypes: pre-cleaved scaffold is completely lethal, akin to the complete deletion of
scaffold, and uncleavable capsid behaves like wildtype 80α. Future experiments are
already in progress in which 80α lysogens carrying pre-cleaved capsid and uncleavable
scaffold mutations will be induced and titered in order to observe their effects on phage
capsid assembly. In addition to plaque assays, EMs of the resulting lysates would also
be helpful in detecting any structural discrepancies generated by these mutations. Once
all four cleavage strains have been tested, it will be interesting to see if the N-terminus of
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capsid is necessary for scaffold-mediated chaperoning, or if scaffold is interacting with a
different area of capsid for this purpose.
In this work, we determined that similar residues at the C-termini of phage and
SaPI1 scaffolds are required for proper procapsid assembly. However, the C-terminal
residue of 80α scaffold R202 and the early N-terminal E50 or E53 residues in capsid were
not involved in a proposed salt bridge interaction. This implies that these two alphahelices are not solely responsible for forming the interface between scaffold and capsid
necessary for capsid assembly, although the I203T compensatory mutants indicate that
these two regions do interact. Additionally, we have also determined that the timing of
scaffold cleavage is significant. Pre-cleaved scaffold results in an inability to form viable
phage progeny, analogous to the complete deletion of scaffold. Uncleavable capsid
behaves comparably to wild-type 80α, indicating that N-terminal cleavage of capsid is not
essential.
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